Tudor Investment Corporation »

Dianthus Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.6M 37k 97.48

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)
Nvidia Corp - US Equity (NVDA)
Micron Technology Inc - US Equity (MU)
Microsoft Corp - US Equity (MSFT)
Ishares Core S&P 500 Etf - US ETP ETF Option Call Option (IVV)
Tesla Inc - US Equity (TSLA)
Ishares Iboxx High Yield Corporate Bond Etf - US E ETF Option Put Option (HYG)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Advanced Micro Devices Inc - US Equity (AMD)
Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Dianthus Therapeutics

FMR
BlackRock
Wellington Management Company
Fairmount Funds Management
Vanguard Capital Management
Avidity Partners Management
Octagon Capital Advisors
TCG Crossover Management
State Street Corporation
Fred Alger Management
Geode Capital Management
VR Adviser
T. Rowe Price Associates
UBS Group
Deerfield Management Company

View all funds holding Dianthus Therapeutics